Dynamic prediction models for graft failure in paediatric kidney transplantation.


Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
26 04 2021
Historique:
received: 08 01 2020
pubmed: 30 9 2020
medline: 23 7 2021
entrez: 29 9 2020
Statut: ppublish

Résumé

Several models have been proposed to predict kidney graft failure in adult recipients but none in younger recipients. Our objective was to propose a dynamic prediction model for graft failure in young kidney transplant recipients. We included 793 kidney transplant recipients waitlisted before the age of 18 years who received a first kidney transplantation before the age of 21 years in France in 2002-13 and survived >90 days with a functioning graft. We used a Cox model including baseline predictors only (sex, age at transplant, primary kidney disease, dialysis duration, donor type and age, human leucocyte antigen matching, cytomegalovirus serostatus, cold ischaemia time and delayed graft function) and two joint models also accounting for post-transplant estimated glomerular filtration rate (eGFR) trajectory. Predictive performances were evaluated using a cross-validated area under the curve (AUC) and R2 curves. When predicting the risk of graft failure from any time within the first 7 years after paediatric kidney transplantation, the predictions for the following 3 or 5 years were accurate and much better with the joint models than with the Cox model (AUC ranged from 0.83 to 0.91 for the joint models versus 0.56 to 0.64 for the Cox model). Accounting for post-transplant eGFR trajectory strongly increased the accuracy of graft failure prediction in young kidney transplant recipients.

Sections du résumé

BACKGROUND
Several models have been proposed to predict kidney graft failure in adult recipients but none in younger recipients. Our objective was to propose a dynamic prediction model for graft failure in young kidney transplant recipients.
METHODS
We included 793 kidney transplant recipients waitlisted before the age of 18 years who received a first kidney transplantation before the age of 21 years in France in 2002-13 and survived >90 days with a functioning graft. We used a Cox model including baseline predictors only (sex, age at transplant, primary kidney disease, dialysis duration, donor type and age, human leucocyte antigen matching, cytomegalovirus serostatus, cold ischaemia time and delayed graft function) and two joint models also accounting for post-transplant estimated glomerular filtration rate (eGFR) trajectory. Predictive performances were evaluated using a cross-validated area under the curve (AUC) and R2 curves.
RESULTS
When predicting the risk of graft failure from any time within the first 7 years after paediatric kidney transplantation, the predictions for the following 3 or 5 years were accurate and much better with the joint models than with the Cox model (AUC ranged from 0.83 to 0.91 for the joint models versus 0.56 to 0.64 for the Cox model).
CONCLUSION
Accounting for post-transplant eGFR trajectory strongly increased the accuracy of graft failure prediction in young kidney transplant recipients.

Identifiants

pubmed: 32989448
pii: 5912715
doi: 10.1093/ndt/gfaa180
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

927-935

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Auteurs

Rémi Kaboré (R)

INSERM, Bordeaux Population Health Research Center, University of Bordeaux, UMR1219, Bordeaux, France.

Loïc Ferrer (L)

INSERM, Bordeaux Population Health Research Center, University of Bordeaux, UMR1219, Bordeaux, France.

Cécile Couchoud (C)

Agence de la Biomédecine, REIN Registry, La Plaine-Saint Denis, France.

Julien Hogan (J)

Pediatric Nephrology Unit, Robert Debré Hospital, Centre de Référence Maladies Rénales Rares Marhea, APHP, Paris, France.

Pierre Cochat (P)

Pediatric Nephrology Unit, Femme-Mère-Enfant Hospital, Lyon University Hospital, Centre de Référence Maladies Rénales Rares Nephrogones, Bron, France.

Laurène Dehoux (L)

Pediatric Nephrology Unit, Necker Enfants-Malades Hospital, Centre de Référence Maladies Rénales Rares Marhea, APHP, Paris Descartes University, Paris, France.

Gwenaelle Roussey-Kesler (G)

Pediatric Nephrology Unit, Femme-Enfant-Adolescent Hospital, Nantes University Hospital, Nantes, France.

Robert Novo (R)

Pediatric Nephrology Unit, Jeanne de Flandre Hospital, Lille University Hospital, Lille, France.

Florentine Garaix (F)

Pediatric Nephrology Unit, Timone-Enfants Hospital, Marseille University Hospital, Marseille, France.

Karine Brochard (K)

Pediatric Nephrology Unit, Children's Hospital, Toulouse University Hospital, Centre de Référence Maladies Rénales Rares Sorare, Toulouse, France.

Marc Fila (M)

Pediatric Nephrology Unit, Arnaud de Villeneuve Hospital, Montpellier University Hospital, Centre de Référence Maladies Rénales Rares Sorare, Montpellier, France.

Cyrielle Parmentier (C)

Pediatric Nephrology Unit, Trousseau Hospital, Centre de Référence Maladies Rénales Rares Marhea, APHP, Paris, France.

Marie-Cécile Fournier (MC)

INSERM UMR 1246-SPHERE, Nantes University, Tours University, Nantes, France.

Marie-Alice Macher (MA)

Agence de la Biomédecine, REIN Registry, La Plaine-Saint Denis, France.
Pediatric Nephrology Unit, Robert Debré Hospital, Centre de Référence Maladies Rénales Rares Marhea, APHP, Paris, France.

Jérôme Harambat (J)

INSERM, Bordeaux Population Health Research Center, University of Bordeaux, UMR1219, Bordeaux, France.
Pediatric Nephrology Unit, Pellegrin-Enfants Hospital, Bordeaux University Hospital, Centre de Référence Maladies Rénales Rares Sorare, Bordeaux, France.
INSERM, Clinical Investigation Center-Clinical Epidemiology-CIC-1401, Bordeaux, France.

Karen Leffondré (K)

INSERM, Bordeaux Population Health Research Center, University of Bordeaux, UMR1219, Bordeaux, France.
INSERM, Clinical Investigation Center-Clinical Epidemiology-CIC-1401, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH